2022
DOI: 10.1016/j.jval.2022.09.591
|View full text |Cite
|
Sign up to set email alerts
|

EE345 Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2-Months Is Cost Effective for the Treatment of HIV-1 in Spain

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles